Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104788370B enables configuration-controlled synthesis of chiral intermediates. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN111978265B details a cost-effective FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant supply chain advantages for API manufacturers.
Patent CN108864189A reveals a novel one-pot synthesis for sulfinamide chiral ligands, enabling cost-effective production of high-purity pharmaceutical intermediates via asymmetric Heck reactions.
Patent CN112920053A reveals a safer, high-yield route for chiral amines used in asthma and cancer drugs, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN116813544B reveals catalyst-free heating method for quinoline synthesis ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN106518758A reveals a novel route for Betrixaban intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111217847B introduces efficient thiosilane ligands for aryl boronation, offering high yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN114560832A reveals a green two-step route to dibenzofurans using visible light and palladium catalysis, offering cost-effective manufacturing solutions.
Patent CN115385916B details a novel chiral phosphoric acid catalyzed route offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110452150B details a mild, one-step synthesis of axial chiral indole-naphthalenes with high enantioselectivity, offering cost-effective solutions for chiral catalyst manufacturing.
Patent CN114751883B reveals a novel Pd-catalyzed carbonylation route for benzofuran-3-carboxamide. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN115772157B details cobalt-catalyzed C-H activation for 2-alkoxyindoles. Offers cost-effective scalable routes for pharmaceutical intermediate manufacturing supply chains.
Novel 4-step synthesis of Apixaban impurity compound 7 ensures high purity for QC. Optimized route reduces costs and improves supply chain reliability for pharmaceutical manufacturers.
Patent CN121378226A reveals a mild synthesis method for oxindole compounds with high yield. This offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN106946704A reveals efficient catalyst-free Wittig route for fused aromatics. Enables cost reduction in fine chemical manufacturing and scalable supply.
Novel Pd-catalyzed cyclization of anilines and alkynes offers high-purity beta-halopyrroles with simplified supply chains and reduced manufacturing costs.
Novel patent CN104530112A offers high-yield Everolimus intermediate synthesis. Reduces costs and improves supply chain reliability for immunosuppressor manufacturing.
Patent CN108409615B reveals a scalable method for enantiopure tert-butyl sulfinamide. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this novel route.
Novel Pd-catalyzed one-pot method for high-purity trifluoromethyl chromone quinoline intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel 2-step synthesis of bifenazate using copper catalysis offers high yield and safety. Ideal for agrochemical intermediate manufacturing scale-up.